Evidence map›Paper›PMID 42549501›Full record

ArticleCirculation research2026

Cardiomyocyte-Specific Inhibition of p53 Signaling as a Therapeutic Strategy for Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.

Laura Lalaguna, Marina López-Olañeta, Carlos Torroja, Carlos Relaño-Rupérez, Carlos Fernández-Sellers, Fátima Sánchez-Cabo, Juan Pablo Ochoa, Esther Zorio, Pablo García-Pavía, Enrique Lara-Pezzi

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Laura LalagunaCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain (L.L., M.L.-O., C.T., C.R.-R., F.-S.-C., J.P.O., P.G.-P., E.L.-P.).ORCID 0000-0002-4737-358X
Marina López-OlañetaCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain (L.L., M.L.-O., C.T., C.R.-R., F.-S.-C., J.P.O., P.G.-P., E.L.-P.).
Carlos TorrojaCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain (L.L., M.L.-O., C.T., C.R.-R., F.-S.-C., J.P.O., P.G.-P., E.L.-P.).ORCID 0000-0001-8914-3400
Carlos Relaño-RupérezCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain (L.L., M.L.-O., C.T., C.R.-R., F.-S.-C., J.P.O., P.G.-P., E.L.-P.).ORCID 0000-0002-1407-9245
Carlos Fernández-SellersPathology Department, Institute of Legal Medicine and Forensic Sciences, Valencia, Spain (C.F.-S.).ORCID 0009-0005-8386-0915
Fátima Sánchez-CaboCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain (L.L., M.L.-O., C.T., C.R.-R., F.-S.-C., J.P.O., P.G.-P., E.L.-P.).ORCID 0000-0003-1881-1664
Juan Pablo OchoaCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain (L.L., M.L.-O., C.T., C.R.-R., F.-S.-C., J.P.O., P.G.-P., E.L.-P.).ORCID 0000-0002-7966-0313
Esther ZorioCAFAMUSME Research Group, IIS La Fe, Valencia, Spain (C.F.-S., E.Z.).ORCID 0000-0003-3608-4210
Pablo García-PavíaCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain (L.L., M.L.-O., C.T., C.R.-R., F.-S.-C., J.P.O., P.G.-P., E.L.-P.).ORCID 0000-0002-5470-2257
Enrique Lara-PezziCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain (L.L., M.L.-O., C.T., C.R.-R., F.-S.-C., J.P.O., P.G.-P., E.L.-P.).ORCID 0000-0002-2743-1033

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

animalscardiomyopathy, dilatedcell deathmyocytes, cardiacsequence analysis, RNAventricular dysfunction

Identifiers

PMID42549501
PMCPMC13574339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.